Author

S. Brietigam

Observed names: Susan Brietigam, Susan S. Brietigam

Institutions: Northwestern University, Cleveland Clinic, Mayo Clinic, University of Arizona, Medical University of South Carolina, Scripps Green Hospital, Scripps Clinic

Observed institutions: Northwestern University, Cleveland Clinic, Mayo Clinic, University of Arizona, Medical University of South Carolina, Scripps Green Hospital, Scripps Clinic, Northwestern Medicine

OpenAlex ID: A5080966437

Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant

2018 · John J. Friedewald, Sunil M. Kurian, et al. · American Journal of Transplantation · 156

Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients

2021 · Sookhyeon Park, Kexin Guo, et al. · Clinical Journal of the American Society of Nephrology · 84

Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform

2017 · S.M. Kurian, E. Velazquez, et al. · American Journal of Transplantation · 37

Molecular Signature in the Peripheral Blood for Sub-Clinical Acute Kidney Rejection.

2014 · J. Friedewald, S. Kurian, et al. · Transplantation · 1

Molecular Phenotyping of Kidney Biopsies By Global Gene Expression Tightly Correlates With Histology Phenotypes and Long-Term Outcomes.

2014 · S. Kurian, B. Modena, et al. · Transplantation

Works count: 5

Citation count: 278

H-index: 3

I10-index: 3